Desai, Anmol
O’Neal, Lauren
Reinis, Kia
Brown, Cristal
Stefanowicz, Michael
Kuang, Audrey
Agrawal, Deepak
Bhavnani, Darlene
Mercer, Tim http://orcid.org/0000-0002-8831-0569
Funding for this research was provided by:
Gilead Sciences (IN-US-987-6016)
Article History
Received: 3 April 2023
Accepted: 6 August 2023
First Online: 17 August 2023
Declarations
:
: This first phase of the Erase Hep C study was approved by the University of Texas at Austin’s Institutional Review Board, as well as CommUnityCare’s Research and Quality Improvement Committee. Written voluntary informed consent was obtained from study participants for the qualitative interviews.
: Not applicable.
: The authors declare no competing interests.